List of works - Firat Yalniz

A Pilot Trial of Lirilumab With or Without Azacitidine for Patients With Myelodysplastic Syndrome

scientific article published on 15 June 2018

A phase II study of addition of pracinostat to a hypomethylating agent in patients with myelodysplastic syndromes who have not responded to previous hypomethylating agent therapy

scientific article published on 29 August 2019

Blast phase chronic myelomonocytic leukemia: Mayo-MDACC collaborative study of 171 cases.

scientific article published on 25 April 2018

Chronic cigarette smoking affects left and right ventricular long-axis function in healthy young subjects: a Doppler myocardial imaging study

scientific article published on 17 June 2009

Chronic myeloid leukemia patients who develop grade I/II pleural effusion under second-line dasatinib have better responses and outcomes than patients without pleural effusion.

scientific article

Comparison of International Prognostic Index and NCCN-IPI in 324 patients with de novo diffuse large B-cell lymphoma: a multi-center retrospective analysis

scientific article published on 21 August 2015

First line treatment of chronic phase chronic myeloid leukaemia patients with the generic formulations of imatinib mesylate

scientific article published on 10 May 2014

Jejunal lipoma causing intussusception and gastrointestinal bleeding

scientific article published on 01 December 2008

Outcomes of Chronic Myeloid Leukemia Patients With Early Molecular Response at 3 and 6 Months: A Comparative Analysis of Generic Imatinib and Glivec.

scientific article published on 4 August 2017

Prognostic Role of Gene Mutations in Chronic Myelomonocytic Leukemia Patients Treated With Hypomethylating Agents.

scientific article published on 25 April 2018

Prognostic significance of baseline FLT3-ITD mutant allele level in acute myeloid leukemia treated with intensive chemotherapy with/without sorafenib

scientific article published on 24 June 2019

Relapse after allogeneic hematopoietic stem cell transplant in patients with chronic myeloid leukemia: tyrosine kinase inhibitors, donor lymphocyte infusions or both?

scientific article published on 28 March 2015

Safety and Efficacy of Infliximab Therapy in the Setting of Steroid-Refractory Acute Graft-versus-Host Disease.

scientific article published on 08 May 2017

Severe odynophagia in a patient developing after azithromycin intake: a case report.

scientific article published on 3 February 2010

Significance of minimal residual disease monitoring by real-time quantitative polymerase chain reaction in core binding factor acute myeloid leukemia for transplantation outcomes

scientific article published on 26 February 2020

Sorafenib plus intensive chemotherapy improves survival in patients with newly diagnosed, FLT3-internal tandem duplication mutation-positive acute myeloid leukemia

scientific article published on 16 July 2019

Steroid Refractory Chronic Graft-Versus-Host Disease: Cost-Effectiveness Analysis

scientific article published on 14 March 2018

Targeting BCL2 in Chronic Lymphocytic Leukemia and Other Hematologic Malignancies

scientific article published on 01 August 2019

The efficacy of generic formulations of imatinib mesylate in the treatment of chronic myeloid leukemia

scientific article published on 06 May 2014

The protoskolicidal effect of 1% polyvinylpyrrolidone-iodine (PVP-1) and 2% taurolidine on abdominal hydatidosis

scientific article published on January 2010

Therapy related-chronic myelomonocytic leukemia (CMML): Molecular, cytogenetic, and clinical distinctions from de novo CMML.

scientific article published on 11 October 2017

Third-line treatment with second-generation tyrosine kinase inhibitors (dasatinib or nilotinib) in patients with chronic myeloid leukemia after two prior TKIs: real-life data on a single center experience along with the review of the literature.